Histamine and learning-memory and convulsion
Histamine and learning-memory and convulsion
批准号:
05454663
负责人:
WATANABE Takehiko
金额:
$4.35万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our major findings of the studies are as follows.(1) When the histaminergic neuron system is activated pharmacologically, the duration periods of electroconvulsion are shortened. On the other hand, when the neuron is inactivated, the duration periods are prolonged. Thus, histamine is anticonvulsant.(2) The threshold of electroconvulsion is lower in young mice (3 weeks) than in adult mice (>6 weeks), and the value is decreased further by an H1 antagonist, pyrilamine, but not by terfenadine, a non-sedative antihistaminic. These findings are consistnet with our clinical observation that the symptoms of some patients of epilepsy became worse when ketotifen was prescribed for allergic diseases, but they are well controlled when terfenadine was used.(3) Thioperamide, an H3 antagonist, shoretend the latency in passive avoidance test of senescence accelerated mice. When the brain histamine level was decreased by treatment with an inhibitor of histidine decarboxylase, the death of neural cells … More in CA 2 region of the hippocampus of gerbils subjected to ischemia by a transient occlusion of the carotid arteries was promoted compared to control group. These findings suggest that the histaminergic system is involved in learning and memory processes.(4) The double label autoradiography of a brain section was developed by taking advantage of the difference in the half-lives of 3H and 11C.The application of the method showed that H3 receptros are modulated by dopaminergic neurons through D1 receptors.(5) The distribution of H1 receptors in the living human brain was mapped by PET with [11C] doxepin as a tracer. Its density decreased by aging in the ratio of 13 % per a decade. The density was higher in the foci of abnormal discharge of patients with complex partial seizure than in the opposite side, showing that the H1 receptors are up-regulated in the foci. The observation is in good agreement with the idea that brain histamine is anticonvulsant, which was obtained by pharmacological studies described above. The density was significantly lower in the cerebral cortices of patients of Alzheimer'disease or multiinfarct dementia than the age- and sex-matched normal controls. Less
期刊论文(112)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Sugimoto: "Histamine depletion in brain caused by treatment woth (S)-α-fluoro methyl-histidine enhances ischemic damage of gerbil hippocampal CA2 neurons." Brain Res.666. 279-283 (1994)
K.Sugimoto:“(S)-α-氟甲基组氨酸治疗引起的大脑组胺消耗增强了沙鼠海马 CA2 神经元的缺血性损伤。”Brain Res.666 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Yanai: "Clinical PET in Oncology" World Scientific, 4 (1994)
K.Yanai:“肿瘤学中的临床 PET”《世界科学》,4 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Onodera: "Effects of alpha-fluoromethylhistidine on brain histamine and noradrenaline in muricidal rats." Meth.Find.Exp.Clin.Pharmacol.15. 423-427 (1993)
K.Onodera:“α-氟甲基组氨酸对杀人大鼠脑组织胺和去甲肾上腺素的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Yanai: "Labelling of histamine H1, H2 and H3 antagonists with carbon-11 : Radiopharmaceuticals for PET studies." Clinical PET in Oncology. 367-370 (1994)
K.Yanai:“用碳 11 标记组胺 H1、H2 和 H3 拮抗剂:用于 PET 研究的放射性药物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yokoyama: "A histamine H1-antagonist,ketotifen produced seizures in an epileptic child activation study of d-chlorpheniramine on EEG." Meth.Find.Exp.Clin.Pharmacol.15. 183-188 (1993)
H.Yokoyama:“一种组胺 H1 拮抗剂酮替芬在脑电图上 D-氯苯那敏的癫痫儿童激活研究中引起癫痫发作。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 49 条
Studies on Brain Histamine Neurons Using Gene-Targetted Mice
-
批准号:10044229
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$9.79万
-
财政年份:1998
-
负责人:WATANABE Takehiko
-
依托单位:
Regulation of histamine synthesis and degradation at the gene level
-
批准号:08044230
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$7.62万
-
财政年份:1996
-
负责人:WATANABE Takehiko
-
依托单位:
Molecular pharmacology of histamine system
-
批准号:08407005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$23.23万
-
财政年份:1996
-
负责人:WATANABE Takehiko
-
依托单位:
The soldering aluminum alloys containing high amounts of Mg with aid of ultrasonic vibration
-
批准号:07555218
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1995
-
负责人:WATANABE Takehiko
-
依托单位:
Drug development with histamine H3 receptor as a target
-
批准号:05557008
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1993
-
负责人:WATANABE Takehiko
-
依托单位:
New perspectives in research for histaminergic functions in CNS
-
批准号:05044147
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$6.72万
-
财政年份:1993
-
负责人:WATANABE Takehiko
-
依托单位:
A Study on the Development of an Insert Metal for Welding
-
批准号:01460226
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1989
-
负责人:WATANABE Takehiko
-
依托单位:
Histamine as a neurotransmitter: Fluorescence immunohistochemistry of its synthetic and degradative enzymes and purification of histamine receptor protein.
-
批准号:59480132
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1984
-
负责人:WATANABE Takehiko
-
依托单位:
海外基金